UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-35721 DELEK LOGISTICS PARTNERS, LP (Exact name of registrant as specified in its charter) Delaware 45-5379027 (State or other jurisdi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 18 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-38142 DELEK US HOLDINGS, INC. (Exact name of registrant as specified in its charter) | Delaware | | 35-2581557 | | --- | --- | --- | ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission file number: 001-16853 SBA COMMUNICATIONS CORPORATION (Exact name of Registrant as specified in its charter) Florida 6 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-32593 Global Partners LP (Exact name of registrant as specified in its charter) Delaware (State or other jurisdicti ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ___________________________________ FORM 10-K Capital City Bank Group, Inc. (Exact name of Registrant as specified in its charter) | 0-13358 | | --- | ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Florid ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 3, 2026 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______to ______ Commission file number: 001-31829 CARTER'S, INC. (Exact name of registrant as specified in its charter) incorporation or organization) Delaware 13-39 ...

Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the fiscal year ended December 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-8424 Sabine Royalty Trust (Exact name of registrant as specified in its charter) | Texas | 75-6297143 | | --- | --- | | ...

Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No þ The aggregate market value of the registrant's commo ...

Revenue and Financial Performance - Revenue charges of approximately $422 million in 2025 are driven by one-time commercial actions to prepare the India commercial business for sale[24]. - At December 31, 2025, FMC's net financial instrument position was a net liability of $9.5 million, a change from a net asset of $34.1 million at December 31, 2024[338]. - As of December 31, 2025, the net asset position was $(9.5) million, compared to a net asset position of $34.1 million at December 31, 2024[341]. Asset Management - Long-lived assets decreased from $5,171.2 million in 2024 to $3,512.6 million in 2025, with significant declines in Europe, Middle East, and Africa (from $3,685.4 million to $2,357.9 million) and Latin America (from $278.8 million to $187.6 million)[27]. - The debt portfolio composition at December 31, 2025, consisted of 82% fixed-rate debt and 18% variable-rate debt[343]. Research and Development - The company has a robust R&D pipeline featuring 16 new active areas in discovery and 19 new active ingredients in development[43]. - FMC's R&D focuses on environmentally sound solutions, with continuous investment in high-quality equipment at facilities like the FMC Stine Research Center[62]. Product Portfolio - The core portfolio includes Rynaxypyr active, generating approximately $0.8 billion in annual revenues for 2025, with a pipeline of eleven new products expected to launch this decade[42]. - The growth portfolio includes Cyazypyr active, which generated revenues of approximately $0.4 billion in 2025, with seven new products expected to launch this decade[44]. Sustainability and Environmental Goals - The company aims for net-zero GHG emissions and has established multiple sustainability goals, including waste and water management[71]. - FMC is committed to phasing out Highly Hazardous Pesticides (HHPs), which accounted for approximately 0.1% of total sales in 2025[72]. Safety and Workforce - As of December 31, 2025, FMC employed approximately 5,500 people, with 39% in Asia and 21% in North America[65]. - FMC's Total Recordable Incident Rate (TRIR) is 0.1491, placing it in the top decile of peer companies in North America for safety performance[70]. Risk Management - The primary currencies for FMC's exchange rate exposure include the U.S. dollar against the Brazilian real, Chinese yuan, and euro[339]. - FMC's risk management program includes the use of derivative contracts to minimize exposure to commodity prices, interest rates, and foreign currency exchange rates[336]. Competitive Strategy - FMC's competitive strategy includes providing advanced technology and high product quality while maintaining cost efficiency[60]. - FMC's growth strategy focuses on developing environmentally compatible solutions and acquiring complementary technologies to enhance its product portfolio[39]. Patent and Legal Matters - The company owns approximately 162 active granted U.S. patents and 2,133 active granted foreign patents as of December 31, 2025[48]. - FMC has initiated several patent enforcement proceedings against generic producers, resulting in favorable judgments and settlements in multiple countries[52]. - Atticus LLC settled a patent dispute with FMC, allowing commercialization of CTPR-containing products[55]. Investments and Collaborations - FMC Ventures continued to support collaborations and investments in start-ups focusing on disruptive technologies in 2025[41]. - The Arc™ farm intelligence platform is now available in over 25 countries across 20 million acres, helping farmers manage pest pressure more efficiently[40].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-36434 FIRST MID BANCSHARES, INC. (Exact name of Registrant as specified in its charter) (State or other jurisdiction of incorporation or organ ...